UK markets closed

Hims & Hers Health, Inc. (HIMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
13.12+0.08 (+0.61%)
At close: 04:00PM EST
13.11 -0.01 (-0.08%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close13.04
Open13.16
Bid13.11 x 3000
Ask13.15 x 2200
Day's range12.73 - 13.30
52-week range5.65 - 13.91
Volume6,492,281
Avg. volume3,549,196
Market cap2.811B
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

    SAN FRANCISCO, February 26, 2024--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2023 in a shareholder letter that is posted at investors.hims.com.

  • Business Wire

    Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer

    SAN FRANCISCO, February 20, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer. Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding.

  • Business Wire

    Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

    SAN FRANCISCO, February 05, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.